Barrios PE, Martínez CDA, Panduro BJG, Fajardo DS

Idioma: Español
Referencias bibliográficas: 11
Paginas: 417-420
Archivo PDF: 228.23 Kb.

RESUMEN

Se describe el caso de una paciente con anticuerpos anti-Ro/SSA sin ningún otro factor de riesgo ni datos de enfermedad de la colágena. En su primer embarazo se identificó bloqueo cardiaco fetal congénito e hidrops fetal, que causaron la muerte del feto. En el segundo embarazo el tratamiento permitió que la paciente diera a luz una niña sana.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mayer O. Anti-SSA/Ro and Anti-SSB/La antibodies. What’s new? Ann Med Interne 2002;153:520-529.

2. Cavazzana I, Franceschini F, Belfiore N, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSA: Clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001;19:403.

3. Phan TG, Wong RC, Adelstein S. Autoantibodies to extractable nuclear antigens: Making detection and interpretation more meaningful. Clin Diagn Lab Immunol 2002;9:1.

4. Buyon JP, Hiebert R, Copel J et al. Autoinmmune associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from de national lupus registry. J Am Coll Cardiol 1998;31:1658-1656.

5. Jaeggi ET, Fouron JC, Silverman ED et al. Transplacental treatment improves the outcome of prenatally diagnosed complete atriventricular block without structural heart disease. Circulation 2004;110:1542-1548.

6. Jaeggi ET, hamilton RM, Silverman ED et al. Outcome of children with fetal, neonatal or childhood diagnosis of isolated complete heart block. A single institution’s experience of 30 years. J Am Coll Cardiol 2002;39:130-137.

7. Salmonsson S, Sonesson SE, Ottosson L et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis and mediate congenital heart block. J Exp Med 2005;201:11-17.

8. Rivera TL, Izmirly PM, Birnbaum BK et al. DIsease progresión in mother of children enrolled in the research registry for neonatal lupus. Ann Rheum Dis 2009;68:828.

9. Ramsey-Goldman R, Hom D, Deng JS et al. Anti-SSA antibodies and the fetal outcome in maternal systemic lupus erythematosus. Arthritis Rheum 1986;29:1269-1273.

10. Boutjdir M. Molecular and ionic basis of congenital complete heart block. Trends Cardiovasc Med 2000;10;114-122.

11. Friedman DM, Kim MY, Copel JA et al. Prospective evaluation of fetuses with autoinmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) study. Am J Cardiol 2009;03:1102.